Skip to main content

Table 1 Patient related characteristics

From: Variation in guideline adherence in non-Hodgkin’s lymphoma care: impact of patient and hospital characteristics

Characteristics Patients (N TOTAL  = 423)
Patient factors N %
Male sex 242 57
Mean age, years (range) 423 66 (22–94)
Co-morbidities (≥1) 256 61
Objections (patient preferences)A 25 6
Good performance statusB 67 94
Tumor related factors
Previous malignancies 71 17
Extranodal involvement 258 61
High LDH levelC 171 44
Aberrant Hb levelD 173 42
Ann Arbor stage III/IV 268 68
Aggressive tumor 254 60
DLBCL tumor typeE 194 46
IPI score (intermediate-) highB 49 38
Professional related factors
In-hospital referral 270 64
Multidisciplinary team consultation 172 41
Discussed in pathology panel 137 33
Therapy usedF 319 75
  1. Abbreviations: LDH lactate-dehydrogenase, Hb Hemoglobin, DLBCL diffuse large B-cell lymphoma, IPI International Prognostic Index
  2. AExcluded from further analyses due to <10 % variation
  3. BExcluded from further analyses due to >50 % missings, based on
  4. WHO and Karnofsky scores
  5. CHigh LDH level is defined as >250 U/l
  6. DAberrant Hb level is defined as <8.5 or >11 mmol/l for males and<7.5 or >10 mmol/l for females
  7. ENon-DLBCL tumor types include follicular lymphoma (18 %),
  8. marginal zone B-cell lymphoma (11 %), mantle-cell lymphoma (5 %),
  9. lympho(plasma)cytic lymphoma (10 %), and miscellaneous (9 %)
  10. FThe watch-and-wait management was coded as ‘no therapy used’